Medtronic Jewel AF ICD Approvable With Conditions, FDA Panel Says
This article was originally published in The Gray Sheet
Executive Summary
Medtronic expects FDA approval of its Jewel AF dual chamber implantable cardioverter defibrillator by the end of the year following a unanimous (4-0) approval with conditions recommendation June 24 from the agency's Circulatory System Devices Panel.